Judge Orders Reinstatement of NIH Grants Cut Under Trump-Era Policy

A federal judge has ordered the National Institutes of Health to restore funding to over 200 grants previously revoked due to a Trump-era policy aimed at barring collaborations with Chinese institutions. The decision came after a lawsuit filed by affected researchers, who argued the cuts were politically motivated and lacked due process. The judge agreed that NIH violated proper procedures, failing to offer clear justifications or avenues for appeal. This ruling may set a precedent for future grant disputes and highlights concerns about science politicization. The NIH must now reconsider the grant terminations under lawful processes, and possibly restore millions in halted research funds. (Science)

Trump Removes Head of Nuclear Safety Agency in Surprise Move

Donald Trump has dismissed the chair of the Defense Nuclear Facilities Safety Board, a critical oversight body for U.S. nuclear weapons complexes. The firing, which came without clear justification, alarmed safety experts and watchdogs, who fear it will weaken oversight at facilities known for hazardous operations. The ousted commissioner had recently clashed with Trump officials over transparency and safety protocols. Her dismissal raises questions about political interference in agencies responsible for national security and public safety. Critics worry the decision could destabilize the board’s operations and diminish its ability to hold the Department of Energy accountable. (Ars Technica)

---

U.S. Halts Key Research Collaboration with South Africa Over Trump Policy

The U.S. government has suspended a long-running HIV and TB research partnership with South Africa’s leading medical research agency, citing restrictions enacted under the Trump administration. The collaboration, funded by NIH, supported groundbreaking work and critical training. South African scientists were shocked by the abrupt decision, which came without detailed explanation. The policy in question appears to link research support with geopolitical objectives, raising alarm over political motives interfering with global health cooperation. The suspension threatens vital progress in infectious disease research and highlights ongoing international fallout from Trump-era science policies. (New York Times)

Breakthrough HIV Drug May Be Too Expensive to End Epidemic

The HIV-prevention drug lenacapavir, hailed as a potential game-changer for ending the epidemic, may be priced too high to deliver widespread impact. Manufactured by Gilead, the injectable drug requires dosing only twice a year. However, the estimated cost—between $800 and $36,500 per person per year—makes it unaffordable for many low- and middle-income countries. Health advocates warn that unless Gilead licenses it for generic production, the drug’s global reach will be limited. Experts stress the urgent need for equitable access to this tool if the world hopes to meet HIV eradication goals. (The Guardian)

---

Pharma Giants Invest in Cancer Drugs That May Replace Chemotherapy

Pfizer, AstraZeneca, and Merck are heavily investing in antibody-drug conjugates (ADCs), a next-generation cancer therapy that targets tumors more precisely than traditional chemotherapy. ADCs combine monoclonal antibodies with toxic payloads to attack cancer cells while sparing healthy tissue. Encouraged by promising clinical data and FDA approvals, drugmakers are acquiring biotech firms and ramping up development. Experts see ADCs as a potential replacement for broad-spectrum chemo, offering fewer side effects and better patient outcomes. However, high costs and manufacturing complexity pose challenges. Still, the ADC market is expected to reach $25 billion by 2030. (CNBC)

Study Links Early Antibiotic Use to Later Infections in Children

A recent study shows that administering antibiotics early in life may increase children’s risk of developing drug-resistant infections later. Researchers analyzed health records and found that infants given antibiotics in their first two years were more likely to experience multiple infections and require further antibiotics by age five. The findings add to growing evidence about the long-term impact of early-life antibiotic exposure on the microbiome and immunity. Scientists caution against unnecessary prescriptions and urge more targeted antimicrobial stewardship in pediatrics. Overprescription could lead to a cycle of dependence on increasingly potent antibiotics. (CIDRAP)

Banks Continue Fossil Fuel Financing Despite Climate Commitments

Major global banks are still heavily funding fossil fuel projects despite pledging to align with net-zero emissions goals. A new analysis finds that since the Paris Agreement, banks have provided trillions in loans and underwriting to coal, oil, and gas companies. Many of these banks belong to climate alliances yet continue backing high-emissions ventures, particularly in the Global South. Activists argue this undermines international climate targets and accelerates environmental degradation. Institutions defend their role, citing energy security and gradual transition needs. Critics call for stricter accountability mechanisms and more transparent climate finance disclosures. (Inside Climate News)

Food Industry Faces Pressure Over Use of Artificial Dyes

Consumer pressure and regulatory scrutiny are forcing food manufacturers to reconsider artificial dyes. Kraft Heinz, under investigation, is reviewing its use of chemicals linked to hyperactivity in children. Many of these dyes are banned or restricted in Europe but remain widely used in U.S. food products. Lawmakers and advocacy groups are urging reform, citing health concerns and consumer rights. Kraft Heinz claims to be transparent and compliant with regulations, but critics argue for a full shift to natural coloring. The debate reflects broader tensions over food safety standards and regulatory lag in the U.S. (New York Times)

AI Powerhouse Microsoft Expands Web of Alliances Beyond OpenAI

Microsoft is forging partnerships with several OpenAI rivals to diversify its artificial intelligence ecosystem. While still backing OpenAI, the company is investing in alternative platforms like Mistral and Inflection to reduce dependency and ensure flexibility. This move reflects growing competition in generative AI and concerns about governance, cost, and innovation bottlenecks. By supporting a variety of models, Microsoft aims to offer enterprise customers a broader range of tools. Industry watchers say this diversification strategy may redefine platform loyalty in the AI race and signal a shift toward a more open, multi-model future. (Axios)

Colorado Dinosaur Tracks May Reveal Ancient Mating Rituals

Paleontologists studying fossilized tracks in Colorado believe they’ve found evidence of a dinosaur mating display area, likened to a “Cretaceous dance floor.” The site contains numerous large scrape marks, consistent with courtship behavior observed in modern birds. The findings support the idea that some dinosaurs engaged in complex mating rituals, strengthening the evolutionary link between birds and dinosaurs. These trace fossils offer rare insights into non-feeding, non-travel behaviors. Researchers say the discovery opens new avenues for understanding dinosaur social dynamics and mating strategies beyond bones and body fossils. (Science)

Louvre Shuts Down Amid Chaos from Overcrowding and Long Waits

The Louvre Museum in Paris abruptly closed due to overwhelming crowds and unmanageable entry lines. Tourists complained of five-hour waits and confusion at entrances. Museum officials cited safety concerns and apologized for the lack of advance warning. Visitors expressed frustration over lost time and money. The closure reflects growing challenges for world-renowned tourist destinations struggling with post-pandemic visitor surges. Officials are reviewing ticketing and crowd control strategies to prevent future shutdowns. The unexpected closure highlights broader issues of over-tourism and museum accessibility during peak travel seasons. (AP)

Transparent, Biodegradable Paper Aims to Replace Ocean-Polluting Plastics

Researchers in Japan have developed the world’s first transparent, thick, and biodegradable paper strong enough to be used for drink containers. Made from finely processed cellulose dissolved in a lithium bromide solution, the material is flexible, durable when wet, and fully decomposable by ocean microorganisms. Its transparency makes it suitable for commercial food packaging, addressing a key industry demand. The project was led by Noriyuki Isobe of JAMSTEC, inspired by deep-sea plastic pollution he observed firsthand. Prototype cups were tested at ocean depths of up to 5,552 meters and successfully decomposed within months. The innovation offers a promising alternative to plastic but remains costly and limited to lab production. The team is now exploring scalable, energy-efficient manufacturing methods and hopes industry adoption will drive down costs. (Asahi)

Thanks for reading. Let’s be careful out there.

WORDS: The Biology Guy.

---

---